Iptacopan Hydrochloride Monohydrate
Iptacopan Hydrochloride Monohydrate, marketed under the brand name Fabhalta, is a novel oral medication classified as a complement factor B inhibitor. It is primarily used to treat rare blood and kidney disorders. Reference standards of Iptacopan Hydrochloride Monohydrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Iptacopan Hydrochloride Monohydrate
[catalogue_number] => PA 09 1680000
[category_ids] => ,82,79,78,70,69,
[chemical_name] =>
[weight] => 477
[form] => C25H33ClN2O5
[cas] => 2447007-60-3
[pslug] => 2447007-60-3-iptacopan-hydrochloride-monohydrate-pa091680000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Iptacopan Hydrochloride Monohydrate